Cormorant Private Healthcare Fund IV LP is 10% Owner at MoonLake Immunotherapeutics (MLTX). They have made 1 open-market trade across 1 company since 2023, most recently 2023-10-04.
CIK 0001871297
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $33.6M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MLTX | 8,367,498 | $81.7M |
Shares reported on the most recent Form 4, priced at the 2023-10-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MLTX | BUY | 2023-10-02 | 2023-10-04 | $57.30 | $33.6M | +2.1% | -13.5% | +0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.